Olopan 0.1% (Ophthalmic Solution)
5 ml drop: ৳ 110.00
Medicine Details
Category | Details |
---|---|
Generic | Olopatadine hydrochloride |
Company | Beximco pharmaceuticals ltd |
Also available as |
Title and Categories
- Patadin Eye Drops
- Olopan Nasal Spray
- Olopan Tablet
- Ophthalmic Non-Steroid drugs
Indications
- Treatment of allergic conjunctivitis
- Relief of symptoms of seasonal allergic rhinitis
- Treatment of allergic rhinitis and allergic skin conditions
Dosage
- 0.1% solution for affected eye two times per day
- 0.2% solution for affected eye once a day
- 0.7% solution for affected eye once a day
- Olopatadine Nasal Spray: Two sprays per nostril twice daily for adults and adolescents
- Olopatadine Nasal Spray: One spray per nostril twice daily for children 6 to 11 years of age
- Olopatadine Tablet: 5 mg dosage for adults twice daily
- Olopatadine Tablet: 5 mg dosage for children 7 years old or over twice daily
Mode of Action
- Blocks the action of histamine in the body
- Stabilizes mast cells
- Acts as an antagonist at histamine H1 receptors
Pharmacology
- Reduces allergy symptoms such as sneezing, itching, and runny nose
- Absorbed with individual peak plasma concentrations observed between 30 minutes and 1 hour
- Moderate protein binding at approximately 55% in human serum
- Eliminated through urinary excretion
Administration
- Instructions for using the Nasal Spray
- Cleaning procedures for the Nasal Spray
Interaction
- No formal drug-drug interaction studies conducted
- No anticipated drug interactions with inhibitors of liver enzymes
Contraindications
- Known hypersensitivity to any component of the product
- Not recommended for use in case of allergy to olopatadine
Side Effects
- Reported side effects include headaches, asthenia, blurred vision, and more
Pregnancy & Lactation
- Not teratogenic in rats and rabbits
- Caution advised in pregnant and nursing women
Precautions & Warnings
- Advice on contact lens usage and application of ophthalmic solution
- Instructions for using Olopan Nasal Spray
- Guidance on the use of Olopan Tablet
Use in Special Populations
- No overall differences in safety or effectiveness observed in geriatric use
Overdose Effects
- No specific information on Olopan overdose
Therapeutic Class
- Belongs to Ophthalmic Non-Steroid drugs
Storage Conditions
- Store at room temperature
- Protect from light
- Desirable that the contents should not be used more than one month after first opening
Related Brands
- OPT 0.7% (Ophthalmic Solution) - unido-pharmaceuticals-ltd
- Opatin 665 mcg/spray (Nasal Spray) - opsonin-pharma-ltd
- Olacing Max 0.7% (Ophthalmic Solution) - pacific-pharmaceuticals-ltd
- Olonex 5 mg (Tablet) - beacon-pharmaceuticals-plc
- Allet Max 0.7% (Ophthalmic Solution) - healthcare-pharmaceuticals-ltd